 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transferase
|
 |
|
Title:
|
 |
Mutant enzyme l119f lumazine synthase from s.Pombe
|
|
Structure:
|
 |
6,7-dimethyl-8-ribityllumazine synthase. Chain: a, b, c, d, e. Engineered: yes. Mutation: yes
|
|
Source:
|
 |
Schizosaccharomyces pombe. Fission yeast. Organism_taxid: 4896. Expressed in: escherichia coli. Expression_system_taxid: 562.
|
|
Biol. unit:
|
 |
Pentamer (from
)
|
|
Resolution:
|
 |
|
3.10Å
|
R-factor:
|
0.194
|
R-free:
|
0.231
|
|
|
Authors:
|
 |
S.Gerhardt,I.Haase,S.Steinbacher,J.T.Kaiser,M.Cushman, A.Bacher,R.Huber,M.Fischer
|
Key ref:
|
 |
S.Gerhardt
et al.
(2002).
The structural basis of riboflavin binding to Schizosaccharomyces pombe 6,7-dimethyl-8-ribityllumazine synthase.
J Mol Biol,
318,
1317-1329.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
06-Feb-02
|
Release date:
|
24-Jul-02
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
Q9UUB1
(RIB4_SCHPO) -
6,7-dimethyl-8-ribityllumazine synthase
|
|
|
|
Seq: Struc:
|
 |
 |
 |
159 a.a.
147 a.a.*
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 1 residue position (black
cross)
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.2.5.1.9
- Riboflavin synthase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
2 6,7-dimethyl-8-(1-D-ribityl)lumazine = riboflavin + 4-(1-D- ribitylamino)-5-amino-2,6-dihydroxypyrimidine
|
 |
 |
 |
 |
 |
2
×
6,7-dimethyl-8-(1-D-ribityl)lumazine
|
=
|
riboflavin
|
+
|
4-(1-D- ribitylamino)-5-amino-2,6-dihydroxypyrimidine
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
riboflavin synthase complex
|
3 terms
|
 |
|
Biological process
|
riboflavin biosynthetic process
|
1 term
|
 |
|
Biochemical function
|
transferase activity
|
2 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
J Mol Biol
318:1317-1329
(2002)
|
|
PubMed id:
|
|
|
|
|
| |
|
The structural basis of riboflavin binding to Schizosaccharomyces pombe 6,7-dimethyl-8-ribityllumazine synthase.
|
|
S.Gerhardt,
I.Haase,
S.Steinbacher,
J.T.Kaiser,
M.Cushman,
A.Bacher,
R.Huber,
M.Fischer.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Riboflavin is an essential cofactor in all organisms. Its direct biosynthetic
precursor, 6,7-dimethyl-8-ribityllumazine, is synthesised by the enzyme
6,7-dimethyl-8-ribityllumazine synthase. Recently, we have found that the enzyme
from Schizosaccharomyces pombe binds riboflavin, the final product of the
pathway with a relatively high affinity with a KD of 1.2 microM. Here, we report
on the crystal structure of lumazine synthase from S. pombe with bound
riboflavin and compare the binding mode with those of the substrate analogue
inhibitor 5-nitro-6-(D-ribitylamino)-2,4(1H,3H)-pyrimidinedione and of the
product analogue 6-carboxyethyl-7-oxo-8-ribityllumazine. In all complexes the
pyrimidinedione moieties of each respective ligand bind in a very similar
orientation. Binding of riboflavin additionally involves a stacking interaction
of the dimethylbenzene moiety with the side-chain of His94, a highly conserved
residue in all lumazine synthases. The enzyme from Bacillus subtilis showed a KD
of at least 1 mM whereas the very homologous enzyme from Saccharomyces
cerevisiae had a comparable KD of 3.9 microM. Structural comparison of the S.
cerevisiae, the S. pombe, and the mutant enzymes suggests that fine tuning of
affinity is achieved by influencing this stacking interaction.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 5.
Figure 5. Pentameric assembly of S. pombe lumazine synthase
viewed along the 5-fold non-crystallographic symmetry axis. The
active sites are built up by two adjacent monomers. Bound
riboflavin is shown in ball-and-stick.
|
 |
Figure 9.
Figure 9. Stereo view of superposition of the active site
residues formed by two adjacent monomers of the yeast lumazine
synthases from S. pombe (red) and S. cerevisiae[16] (blue).
Bound riboflavin (yellow) in case of the S. pombe enzyme is in
almost the same position as the bound inhibitor 5-(6- Image
-ribitylamino-2,4-dihydroxypyrimidine-5-yl)-1-pentyl-phosphonic
acid (green) in case of S. cerevisiae. Numbers refer to amino
acid residues from S. pombe lumazine synthase.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(2002,
318,
1317-1329)
copyright 2002.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
M.Fischer,
and
A.Bacher
(2011).
Biosynthesis of vitamin B2: a unique way to assemble a xylene ring.
|
| |
Chembiochem, 12,
670-680.
|
 |
|
|
|
|
 |
A.Talukdar,
E.Morgunova,
J.Duan,
W.Meining,
N.Foloppe,
L.Nilsson,
A.Bacher,
B.Illarionov,
M.Fischer,
R.Ladenstein,
and
M.Cushman
(2010).
Virtual screening, selection and development of a benzindolone structural scaffold for inhibition of lumazine synthase.
|
| |
Bioorg Med Chem, 18,
3518-3534.
|
 |
|
|
|
|
 |
E.Morgunova,
B.Illarionov,
S.Saller,
A.Popov,
T.Sambaiah,
A.Bacher,
M.Cushman,
M.Fischer,
and
R.Ladenstein
(2010).
Structural study and thermodynamic characterization of inhibitor binding to lumazine synthase from Bacillus anthracis.
|
| |
Acta Crystallogr D Biol Crystallogr, 66,
1001-1011.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.Talukdar,
M.Breen,
A.Bacher,
B.Illarionov,
M.Fischer,
G.Georg,
Q.Z.Ye,
and
M.Cushman
(2009).
Discovery and development of a small molecule library with lumazine synthase inhibitory activity.
|
| |
J Org Chem, 74,
5123-5134.
|
 |
|
|
|
|
 |
M.Grininger,
H.Staudt,
P.Johansson,
J.Wachtveitl,
and
D.Oesterhelt
(2009).
Dodecin is the key player in flavin homeostasis of archaea.
|
| |
J Biol Chem, 284,
13068-13076.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
L.Rodríguez-Fernández,
F.J.López-Jaramillo,
A.Bacher,
M.Fischer,
and
S.Weinkauf
(2008).
Improvement of the quality of lumazine synthase crystals by protein engineering.
|
| |
Acta Crystallogr Sect F Struct Biol Cryst Commun, 64,
625-628.
|
 |
|
|
|
|
 |
E.Morgunova,
S.Saller,
I.Haase,
M.Cushman,
A.Bacher,
M.Fischer,
and
R.Ladenstein
(2007).
Lumazine synthase from Candida albicans as an anti-fungal target enzyme: structural and biochemical basis for drug design.
|
| |
J Biol Chem, 282,
17231-17241.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.H.Duurkens,
M.B.Tol,
E.R.Geertsma,
H.P.Permentier,
and
D.J.Slotboom
(2007).
Flavin binding to the high affinity riboflavin transporter RibU.
|
| |
J Biol Chem, 282,
10380-10386.
|
 |
|
|
|
|
 |
Y.Zhang,
B.Illarionov,
A.Bacher,
M.Fischer,
G.I.Georg,
Q.Z.Ye,
D.Vander Velde,
P.E.Fanwick,
Y.Song,
and
M.Cushman
(2007).
A novel lumazine synthase inhibitor derived from oxidation of 1,3,6,8-tetrahydroxy-2,7-naphthyridine to a tetraazaperylenehexaone derivative.
|
| |
J Org Chem, 72,
2769-2776.
|
 |
|
|
|
|
 |
A.Ramsperger,
M.Augustin,
A.K.Schott,
S.Gerhardt,
T.Krojer,
W.Eisenreich,
B.Illarionov,
M.Cushman,
A.Bacher,
R.Huber,
and
M.Fischer
(2006).
Crystal structure of an archaeal pentameric riboflavin synthase in complex with a substrate analog inhibitor: stereochemical implications.
|
| |
J Biol Chem, 281,
1224-1232.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
E.Morgunova,
B.Illarionov,
T.Sambaiah,
I.Haase,
A.Bacher,
M.Cushman,
M.Fischer,
and
R.Ladenstein
(2006).
Structural and thermodynamic insights into the binding mode of five novel inhibitors of lumazine synthase from Mycobacterium tuberculosis.
|
| |
FEBS J, 273,
4790-4804.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
K.J.Woycechowsky,
F.P.Seebeck,
and
D.Hilvert
(2006).
Tunnel plasticity and quaternary structural integrity of a pentameric protein ring.
|
| |
Protein Sci, 15,
1106-1114.
|
 |
|
|
|
|
 |
M.Mack,
and
S.Grill
(2006).
Riboflavin analogs and inhibitors of riboflavin biosynthesis.
|
| |
Appl Microbiol Biotechnol, 71,
265-275.
|
 |
|
|
|
|
 |
V.Zylberman,
S.Klinke,
I.Haase,
A.Bacher,
M.Fischer,
and
F.A.Goldbaum
(2006).
Evolution of vitamin B2 biosynthesis: 6,7-dimethyl-8-ribityllumazine synthases of Brucella.
|
| |
J Bacteriol, 188,
6135-6142.
|
 |
|
|
|
|
 |
B.Illarionov,
W.Eisenreich,
N.Schramek,
A.Bacher,
and
M.Fischer
(2005).
Biosynthesis of vitamin B2: diastereomeric reaction intermediates of archaeal and non-archaeal riboflavin synthases.
|
| |
J Biol Chem, 280,
28541-28546.
|
 |
|
|
|
|
 |
M.Cushman,
G.Jin,
T.Sambaiah,
B.Illarionov,
M.Fischer,
R.Ladenstein,
and
A.Bacher
(2005).
Design, synthesis, and biochemical evaluation of 1,5,6,7-tetrahydro-6,7-dioxo-9-D-ribitylaminolumazines bearing alkyl phosphate substituents as inhibitors of lumazine synthase and riboflavin synthase.
|
| |
J Org Chem, 70,
8162-8170.
|
 |
|
|
|
|
 |
M.Fischer,
and
A.Bacher
(2005).
Biosynthesis of flavocoenzymes.
|
| |
Nat Prod Rep, 22,
324-350.
|
 |
|
|
|
|
 |
M.Koch,
C.Breithaupt,
S.GerhardtHaase,
S.Weber,
M.Cushman,
R.Huber,
A.Bacher,
and
M.Fischer
(2004).
Structural basis of charge transfer complex formation by riboflavin bound to 6,7-dimethyl-8-ribityllumazine synthase.
|
| |
Eur J Biochem, 271,
3208-3214.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
V.Zylberman,
P.O.Craig,
S.Klinke,
B.C.Braden,
A.Cauerhff,
and
F.A.Goldbaum
(2004).
High order quaternary arrangement confers increased structural stability to Brucella sp. lumazine synthase.
|
| |
J Biol Chem, 279,
8093-8101.
|
 |
|
|
|
|
 |
I.Haase,
S.Mörtl,
P.Köhler,
A.Bacher,
and
M.Fischer
(2003).
Biosynthesis of riboflavin in archaea. 6,7-dimethyl-8-ribityllumazine synthase of Methanococcus jannaschii.
|
| |
Eur J Biochem, 270,
1025-1032.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
|